China gave the greenlight to Eli Lilly & Co.’s blockbuster drug tirzepatide for use in treating diabetes, a move that will ...
, opens new tab said on Tuesday its diabetes drug tirzepatide has received approval from Chinese regulators, setting up ...
Eli Lilly and Company announced on Tuesday that the National Medical Products Administration (NMPA) in China has approved the ...
Eli Lilly’s (NYSE:LLY) weight-loss drug Zepbound (tirzepatide) will remain in short supply through April-end amid increased ...
El laboratorio estadounidense Eli Lilly destinará 5.300 millones de dólares (4.895 millones de euros) adicionales en su planta de producción de Indiana (Estados Unidos), aumentando así la ...
, opens new tab weight-loss drug Zepbound drove the company to raise its annual sales forecast by $2 billion on Tuesday, lifting its shares nearly 5%. Lilly said it expects significant production ...
Eli Lilly & Co. said Wednesday that two late-stage trials evaluating a 10 mg or 15 mg injection of tirzepatide — the weight-loss drug marketed in the U.S. as Zepbound — reduced the severity of ...
Estimación del precio real de una acción basada en modelos de valoración como el flujo de caja descontado, los múltiplos de valoración por pares y los modelos de descuento de dividendos.
(Bloomberg) -- Eli Lilly & Co.’s shares soared as its brighter outlook for 2024 raised the potential ceiling for new weight-loss drugs even further in the eyes of analysts and investors. Most Read ...
Tuesday, Eli Lilly And Co (NYSE:LLY) reported first-quarter revenue of $8.77 billion, up 26% year over year, marginally missing the consensus of $8.92 billion, driven by increases of 16% in volume and ...
Eli Lily’s weight-loss drug tirzepatide has been shown to “significantly” reduce sleep apnoea severity, the US drugs giant said on Wednesday. The firm said phase 3 clinical trials had showed ...
Consejos que transforman datos financieros complejos en ideas de inversión prácticas y sencillas. Eli Lilly and Company descubre, desarrolla y comercializa productos farmacéuticos de uso humano ...